San Diego-primarily based Viking Therapeutics marked itself as a serious competitor during the weight loss drug current market in February after revealing promising info from a mid-stage demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified to be a weekly injection As well as in March th